A. Pharmacologic Actions [2,3]
- Similar to amphetamines
- Inhibits catecholamine reuptake: norepinephrine, dopamine, epinephrine
- Leads to elevated levels of sympathetic neurotransmitters
- May show slight increase in release of norepinephrine
- Potent Vasoconstriction
- Mediated primarily through alpha-adrenergic receptors
- Increases release of endothelins
- Reduces production of nitric oxide (potent vasodilator)
- Prevents cutaneous vasodilation
- Other Acute Cardiac Effects
- alpha and/or ß-adrenergic effects
- Increased blood pressure
- Increased heart rate
- All lead to increased cardiac oxygen consumption
- Chronic Cardiac Effects
- Myocardial ischemia - silent and/or with angina
- Accelerated atherosclerosis
- Myocarditis
- Cardiomyopathy - dilated and hypertrophic
- Arrhythmias
- Hypertension
- Aortic dissection
- Endocarditis
- Inhibit sodium channels, primarily in the heart
- Widening of QRS interval
- Prolongation of QT interval
- Induces Hyperthermia: Impairs sweating and cutaneous vasodilation
- Psychotropic effects correlate closely with inhibition of dopamine uptake
- Local (usually topical) anesthetic effects
- Nasal Septal Collapse [21]
- May be mistaken for vasculitis
- May induce transient anti-neutrophil cytoplasmic antibodies (ANCA)
- May be mistaken for Wegener's granulomatosis or glomerulonephritis
- Methamphetamine abuse symptoms similar to cocaine [22]
- Highly addictive synthetic sympathomimetic
- Ingestion, smoked, snorted, or injected
- Anorexia, insomnia, tachycardia, tachypnea, hypertension, hyperthermia, seizures
- Hemorrhagic and ischemic strokes and renal failure have occurred
- CNS effects include anxiety, agitation, paranoia, delirium, psychosis
- Metabolized by CYP2D6; drugs that compete with CYP2D6 can increase levels
- Therapies similar to cocaine abuse but avoid haloperidol (CYP2D6 inhibitor)
B. Evaluation of Cocaine Abuse
- High suspicion in young persons with
- Unexplained weight loss
- Evidence of cardiac ischemia
- Poor or declining performance at school or work
- Later stages - becoming antisocial
- Abuse of cocaine highly associated with HIV and Hepatitis B and C Virus infections
- Use with heroin intravenously is called a "speedball"
- Symptoms
- Duration of "high" from cocaine is <30 minutes
- High is followed typically by a "down" lasting hours (or until another dose of cocaine)
- Major "upper" feelings are excitement, hyper-speech, omnipotence
- Anxiety, agitation, paranoia, hallucinations (auditory and visual), delirium
- Frank seizures (stroke) may also occur
- Tachycardia, hypertension, and/or high fevers with no other obvious cause
- Markedly reduced appetite; may lead to substantial weight loss
- Severe headaches, pupillary dilation, eye watering occur as well
- Epistaxis, septal perforation, sinusitis also occur with intranasal abuse
- Psychiatric Abnormalities
- >70% of cocaine abusers have personality disorders
- Confusion is prominant in nearly all patients
- Psychosis with severe agitation is common in acute overdoses
- Chronic use can lead to hallucinations
- Intake of Cocaine
- Snorting - intranasal (most popular)
- Solid (crack) or freebase can be smoked
- Intravenous injection
- Subcutaneously (popping)
- Toxin screen in blood and urine (metabolite benzoylecgonine) is gold standard for therapy
C. Acute Medical Effects of Cocaine Abuse
- Main effects leading to serious problems due to vasospasm and sympathomimetic activity
- Severe peripheral vasoconstriction with hypertension
- May cause hypertensive emergency
- Usually with tachycardia
- Myocardial Ischemia and Infarction (MI) [11,15,18]
- Vasoconstriction (primarily cardiac) and platelet activation
- Chronotropic and inotropic activities of cocaine greatly increase cardiac oxygen demand
- Cocaine stimulates endothelial damage and atherosclerosis as well
- Exacerbated by pre-existing coronary artery disease, smoking, and alcoholism
- Smoking greatly increases risk of cocaine induced MI
- Creatine kinase (CK) elevations are not useful for evaluation of cocaine-induced MI
- Troponin I or T elevations are required to assess cocaine-induced ischemia
- CK elevations without troponin I or T increases are not due to cardiac ischemia
- In patients with acute symptoms, 9-12 hours observation is sufficient to ensure low risk for complications [19]
- Other Cardiac Effects [12,15,18]
- Acute ventricular dysfunction and frank heart failure [10]
- Aortic dissection - uncommon, likely related to severe, acute HTN
- Hemopericardium
- Atrial Arrhythmias: sinus tachycardia, sinus bradycardia, supraventricular tachycardia
- Ventricular Arrhythmias: AIVR, ventricular tachycardia and fibrillation, TDP
- Heart Block: bundle branch block (BBB), complete heart block, asystole
- Brugada pattern can occur (right BBB, ST semgnet elevation in V1, V2, V3)
- Rhabdomyolysis
- Likely related to vasoconstriction
- Significant serum CK occur in rhabdomyolysis
- Acute Renal Failure
- Vasoconstriction is a primary contributor
- Exacerbated by rhabdomyolysis and myoglobinuria
- Hyperthermia [2]
- Cocaine impairs sweating
- Impairs cutaneous vasodilation
- Reduces heat perception
- Central Nervous System
- Induces cerebral vasoconstriction (detectable on MRI angiography) [4]
- Very low doses of cocaine induce these vasocontrictive events
- Seizures and Strokes have been reported
- Pupillary Dilatation
- Risk for spontaneous abortion increased 1.4 fold [7]
D. Acute Therapy [19]
- Supportive therapy is mainstay for acute treatment of overdose
- Sedation
- Benzodiazepines are often very effective and are used first line
- Antipsychotics may be required and are second line
- Treatment of Cocaine-Induced Cardiac Ischemia [11,15]
- All patients receive oxygen and aspirin
- Intravenous nitrates are vasodilators of choice
- Sedation is critical using above agents
- Calcium blockers are moderately effective and can be used for slowing heart rate
- Calcium blockers iv may be preferred in patients with coronary artery spasm
- ß-blockers are contraindicated due to increase in cocaine induced vasosconstriction [3]
- Thrombolytics are generally reserved for resistant cases and used with caution
- Phentolamine (alpha-adrenergic antagonist) can be used for refractory HTN, ischemia
- Patients with no signs of acute ischemia over 9-12 hours may be safely discharged [19]
- Hypertensive Emergency [3]
- Nitroprusside (Nipride®) - caution with renal failure or rhabdomyolysis
- Phentolamine is preferred, may be combined with nitroglycerin
- Benzodiazepines preferred over opiates to sedate patient
- Morphine is useful for pain in cases of cocaine induced ischemia
E. Chronic Cocaine Abuse [17,20]
- Dysphoria / Anxiety
- Sleep Disorders
- Sexual Disorders
- Psychosis
- Myocardial Infarction
- Stroke - hemorrhagic and thromboembolic
- Hepatotoxicity - usually with severe cocaine overdose, often with rhabdomyolysis [8]
- Cognitive deficiency and delay in cocaine-exposed infants [16]
- Treatment of Chronic Abuse
- Prevention of relapse
- Psychological support
- Detoxification Programs and Self-Help Groups
- Behavioral Therapy - mixed results; better if patients' significant others involved
- Acupuncture did not reduce cocaine abuse [14]
- To date, no effective agents to substantially prevent relapse
- Medications for Chronic Abuse
- Desipramine - only effective for depressed patients (no effect on abstinance)
- Seretonin reuptake inhibitors are not effective
- Flupentixol - dopamine receptor antagonist, may be effective in chronic abuse
- Buprenorphine - a mixed opiate agonist/antagonist; may have some efficacy
References
- Acute Reactions to Drugs of Abuse. 2002. Med Let. 44(1125):21
- Crandall CG, Vongpatanasin W, Victor RG. 2002. Ann Intern Med. 136(11):785
- Cocaine. 1996. Med Let. 38(974):43
- Kaufman MJ, Levin JM, Ross MH, et al. 1998. JAMA. 279(5):376
- Holden R and Jackson MA. 1996. Lancet. 347:1052
- Henry JA, Fallon JK, Kicman AT, et al. 1998. Lancet. 351(9118):1784
- Ness RB, Grisso JA, Hirschinger N, et al. 1999. NEJM. 340(5):333
- Jonas MM and Graeme-Cook FM. 2001. NEJM. 344(8):591
- Schneider RK, Levenson JL, Schnoll SH. 2001. Ann Intern Med. 134(5):387
- Missouris CG, Swift PA, Singer DRJ. 2001. Lancet. 357(9268):1586
- Hollander JE. 1995. NEJM. 333(19):1267
- Nallamothu BK, Saint S, Kolias TJ, Eagle KA. 2001. NEJM. 345(5):359
- Reneman L, Booij J, de Bruin K, et al. 2001. Lancet. 358(9296):1864
- Margolin A, Kleber HD, Avants SK, et al. 2002. JAMA. 287(1):55
- Lange RA and Hillis LD. 2001. NEJM. 345(5):351
- Singer LT, Arendt R, Minnes S, et al. 2002. JAMA. 287(15):1952
- Mendelson JH and Mello NK. 1996. NEJM. 334(15):965
- Kloner RA and Rezkalla SH. 2003. NEJM. 348(6):487
- Weber JE, Shofer FS, Larkin L, et al. 2003. NEJM. 348(6):510
- Kosten TR and O'Connor PG. 2003. NEJM. 348(18):1786
- Cami J and Farre M. 2003. NEJM. 349(10):975
- Rowshani AT, Schot LJ, ten Berge IJM. 2004. Lancet. 363(9411):782 (Case Report)
- Methamphetamine Abuse. 2004. Med Let. 46(1188):62